These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13132524)

  • 1. [Allergic reaction in men following vaccination with living yolk tularemia vaccine in cutaneous application].
    DIACHENKO SS; KHIZHINS'KA OP; BUIALO SG
    Mikrobiol Zh; 1953; 15(1):27-32. PubMed ID: 13132524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Remote hyperergic-allergic reactions of the skin following tularemia vaccination].
    Pototskiĭ II
    Vestn Dermatol Venerol; 1967 Feb; 41(2):81-2. PubMed ID: 5620485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case of allergic reaction to living tularemia vaccine].
    BELOSTOTSKAIA EN; MAKSIMOVA EB; MASHKILLEISON AL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jan; 1():97-8. PubMed ID: 14360676
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pronounced reaction after vaccination against tularemia].
    Koldoba LG; Rudenko MI
    Vrach Delo; 1969 May; 5():116-7. PubMed ID: 5368854
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allergic reaction in anti-tularemia vaccination].
    DALMATOV DM
    Sov Med; 1962 Oct; 26():127-8. PubMed ID: 14024762
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in using dry living tularemia vaccine for determination of allergic skin reaction].
    KAZBERIUK NA; LITVINOVA ZI; SADOVNIKOVA RN; PEVZNER GL
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Jun; 27(6):58-61. PubMed ID: 13353701
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitularemic living vaccine in therapy of tularemia].
    CONDREA P; FRANCHE M; VITA A; TEODOROVICI G; DUCA E; DRAGOMIR C; LASCU N; MIHU POPOVICI V; SEGAL I; ENE M
    Igiena; 1954; 2():27-36. PubMed ID: 14357853
    [No Abstract]   [Full Text] [Related]  

  • 8. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
    Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
    Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic reactions and their duration in human following epicutaneous vaccination with living tularemia vaccine prepared on egg yolk].
    MOROZ AP; KHYZHYNS'KA OP; BUIALO Kh
    Mikrobiol Zh; 1955; 17(3):40-5. PubMed ID: 13430402
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities of simultaneous vaccination against tularemia and brucellosis. II. Indices of immunologic transformation in guinea pigs following simultaneous topical vaccination against tularemia and brucellosis].
    PILIPENKO VG; POLIAKOVA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1955 May; 5():9-14. PubMed ID: 14397751
    [No Abstract]   [Full Text] [Related]  

  • 12. An algorithm for treatment of patients with hypersensitivity reactions after vaccines.
    Wood RA; Berger M; Dreskin SC; Setse R; Engler RJ; Dekker CL; Halsey NA;
    Pediatrics; 2008 Sep; 122(3):e771-7. PubMed ID: 18762513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines.
    Nilsson L; Kjellman NI; Bjorksten B
    Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1184-9. PubMed ID: 14662571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine.
    McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS
    Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 16. [History of vaccination against tularemia].
    SIL'CHENKO VS
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Oct; (10):83-9. PubMed ID: 13282489
    [No Abstract]   [Full Text] [Related]  

  • 17. [Association of scarlet fever with vaccination against tularemia].
    MARTINEVSKII IL
    Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():105-6. PubMed ID: 14349283
    [No Abstract]   [Full Text] [Related]  

  • 18. Tularemia vaccines - an overview.
    McMurry JA; Moise L; Gregory SH; De Groot AS
    Med Health R I; 2007 Oct; 90(10):311-4. PubMed ID: 18019188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complete and incomplete antibodies in tularemia. I. Immunization with live vaccine].
    Wagner V; Patera V; Sixtová E; Drnková V; Major F
    Cas Lek Cesk; 1968 Nov; 107(47):1414-7. PubMed ID: 5696565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.